gut
ME
ta
G
enome
A
tlas
Home
Browse
Search
Download
Help
About
Citation
LZX Lab
Introduction
Databases
dbEBV
dbRicePro
gutMEGA
iHypoxia
iCysMod
qPhos
qPTM
Tools
cPhosBac
DeepCalpain
DeepGSH
Deep-PLA
DrugCVar
dSCOPE
pCysMod
prkC-PSP
Result
taxon like '%g__Megasphaera%'
Search content: Taxon = Megasphaera
There are 258 entries with your keyword(s).
Condition
Amyotrophic lateral sclerosis / Normal
Anti-islet cell autoantibodies, Developed / Remained negative
Asymptomatic C. difficile carriers / C. difficile infection
Asymptomatic C. difficile carriers / Normal
Atherosclerotic cardiovascular disease / Normal
Bai / Han
Breast-fed / Placebo formula
C. difficile infection / Donor
C. difficile infection / Normal
C. difficile infection patient 1, 11 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 11 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 11 days post-FTM / 7 days post-FTM
C. difficile infection patient 1, 11 days post-FTM / Donor
C. difficile infection patient 1, 128 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / Donor
C. difficile infection patient 1, 18 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 18 days post-FTM / Donor
C. difficile infection patient 1, 25 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 25 days post-FTM / Donor
C. difficile infection patient 1, 3 days post-FTM / Donor
C. difficile infection patient 1, 3 days pre-FTM / Donor
C. difficile infection patient 1, 65 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 65 days post-FTM / Donor
C. difficile infection patient 1, 7 days post-FTM / Donor
C. difficile infection patient 1, 95 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 95 days post-FTM / Donor
C. difficile infection patient 2, 1 days pre-FTM / Donor
C. difficile infection patient 2, 112 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / Donor
C. difficile infection patient 2, 27 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 27 days post-FTM / Donor
C. difficile infection patient 2, 3 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 3 days post-FTM / Donor
C. difficile infection patient 2, 41 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 41 days post-FTM / Donor
C. difficile infection patient 2, 7 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 7 days post-FTM / Donor
C. difficile infection patient 2, 81 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 81 days post-FTM / Donor
C. difficile infection, Recurrent / Nonrecurrent
C. difficile infection, Reinfection / Nonrecurrent
Caesarean section, Full-term / Pre-term
Children with PZQ, 1.1-2 years / 0-1 years
Children with PZQ, 10.1-13 years / 0-1 years
Children with PZQ, 10.1-13 years / 1.1-2 years
Children with PZQ, 10.1-13 years / 2.1-3 years
Children with PZQ, 10.1-13 years / 3.1-4 years
Children with PZQ, 10.1-13 years / 5.1-6 years
Children with PZQ, 10.1-13 years / 6.1-7 years
Children with PZQ, 10.1-13 years / 7.1-8 years
Children with PZQ, 10.1-13 years / 8.1-9 years
Children with PZQ, 2.1-3 years / 0-1 years
Children with PZQ, 2.1-3 years / 1.1-2 years
Children with PZQ, 3.1-4 years / 0-1 years
Children with PZQ, 3.1-4 years / 1.1-2 years
Children with PZQ, 3.1-4 years / 2.1-3 years
Children with PZQ, 4.1-5 years / 0-1 years
Children with PZQ, 4.1-5 years / 1.1-2 years
Children with PZQ, 4.1-5 years / 2.1-3 years
Children with PZQ, 4.1-5 years / 3.1-4 years
Children with PZQ, 5.1-6 years / 0-1 years
Children with PZQ, 5.1-6 years / 1.1-2 years
Children with PZQ, 5.1-6 years / 2.1-3 years
Children with PZQ, 5.1-6 years / 3.1-4 years
Children with PZQ, 5.1-6 years / 4.1-5 years
Children with PZQ, 6.1-7 years / 0-1 years
Children with PZQ, 6.1-7 years / 1.1-2 years
Children with PZQ, 6.1-7 years / 2.1-3 years
Children with PZQ, 6.1-7 years / 3.1-4 years
Children with PZQ, 6.1-7 years / 4.1-5 years
Children with PZQ, 6.1-7 years / 5.1-6 years
Children with PZQ, 7.1-8 years / 0-1 years
Children with PZQ, 7.1-8 years / 1.1-2 years
Children with PZQ, 7.1-8 years / 2.1-3 years
Children with PZQ, 7.1-8 years / 3.1-4 years
Children with PZQ, 7.1-8 years / 4.1-5 years
Children with PZQ, 7.1-8 years / 5.1-6 years
Children with PZQ, 7.1-8 years / 6.1-7 years
Children with PZQ, 8.1-9 years / 0-1 years
Children with PZQ, 8.1-9 years / 1.1-2 years
Children with PZQ, 8.1-9 years / 2.1-3 years
Children with PZQ, 8.1-9 years / 3.1-4 years
Children with PZQ, 8.1-9 years / 4.1-5 years
Children with PZQ, 8.1-9 years / 5.1-6 years
Children with PZQ, 8.1-9 years / 6.1-7 years
Children with PZQ, 8.1-9 years / 7.1-8 years
Children with PZQ, 9.1-10 years / 0-1 years
Children with PZQ, 9.1-10 years / 1.1-2 years
Children with PZQ, 9.1-10 years / 2.1-3 years
Children with PZQ, 9.1-10 years / 3.1-4 years
Children with PZQ, 9.1-10 years / 5.1-6 years
Children with PZQ, 9.1-10 years / 6.1-7 years
Children with PZQ, 9.1-10 years / 7.1-8 years
Children with PZQ, 9.1-10 years / 8.1-9 years
China, After 2 weeks / Baseline
China, Urban / Rural
Clostridia phase / Bacilli phase
Clostridia phase / Gammaproteobacteria phase
Collected in the inner / Collected in the outer
Colorectal adenoma / Normal
Colorectal cancer / Normal
Consensus molecular subtypes 2 / Consensus molecular subtypes 1
Consensus molecular subtypes 3 / Consensus molecular subtypes 1
Consensus molecular subtypes 3 / Consensus molecular subtypes 2
Constipated after lubiprostone / Normal
Constipated before lubiprostone / Normal
Constipation / Normal
Coronary artery disease / Normal
Crohn's disease / Normal
Crohn's disease / Ulcerative colitis
Crohn's disease Active / Normal
Crohn's disease active onset / Normal
Crohn's disease Active presurgery / Normal
Crohn's disease moderate / Normal
Crohn's disease severe / Normal
Crohn's disease, Active / Active onset
Crohn's disease, Active presurgery / Active
Crohn's disease, Active presurgery / Active onset
Diarrheal Phase 2 / Diarrheal Phase 1
Diarrheal Phase 3 / Diarrheal Phase 1
Diarrheal Phase 4 / Diarrheal Phase 1
Gammaproteobacteria phase / Bacilli phase
High gene count / Low gene count
HIV, Negative / CD4 < 200
Hodgkin lymphoma / Normal
Homogenised / Collected in the outer
Idiopathic rapid eye movement sleep behavior disorder / Normal
Idiopathic rapid eye movement sleep behavior disorder / Parkinson's disease
In the interim period between ciprofloxacin courses / Before ciprofloxacin
Infant 1 month / Mother 1 week prior to delivery
Infant 1 week / Mother 1 week prior to delivery
Infant 1 year / Mother 1 week prior to delivery
Infant 3 months / Mother 1 week prior to delivery
Infant 7 months / Mother 1 week prior to delivery
Infants, 1 week / 4 weeks
Infants, 8 weeks / 24 weeks
Intervention formula / Placebo formula
Juvenile idiopathic arthritis / Normal
Kazakh / Bai
Kazakh / Han
Kazakh / Zhuang
Lactobacillus casei Zhang, 28 days / 0 day
Lactobacillus casei Zhang, 42 days / 0 day
Lactobacillus casei Zhang, 42 days / 28 days
Longevity village communities 40-69 year / Urbanized town communities 40-69 year
Longevity village communities 40-69 year / Urbanized town communities Children
Longevity village communities > 70 year / Longevity village communities 40-69 year
Longevity village communities > 70 year / Urbanized town communities 40-69 year
Longevity village communities > 70 year / Urbanized town communities Children
Madagascar / Central African Republic
Moderate to severe diarrhea / Normal
Mongol / Bai
Mongol / Han
Mongol / Kazakh
Mongol / Uyghur
Mongol / Zhuang
Mother 1 year after delivery / Mother 1 week prior to delivery
Multiple kidney stones / Normal
Multiple sclerosis / Normal
Multiple sclerosis treated / Normal
Multiple sclerosis untreated / Normal
Non-alcoholic fatty liver disease / Normal
Non-alcoholic fatty liver disease, 0-1 fibrosis / > 1 fibrosis
Obese / Normal
Obese patients underwent Roux-en-Y gastric bypass, 3 months / Baseline
Other colorectal conditions / Colorectal adenoma
Other colorectal conditions / Normal
Parkinson's disease / Normal
Post-exclusive enteral nutrition / Pre-exclusive enteral nutrition
Postmenopausal breast cancer / Normal
Premenopausal breast cancer / Normal
Probiotic administration 4 weeks / Baseline
Recovery Phase 2 / Recovery Phase 1
Recovery Phase 3 / Recovery Phase 1
Rett syndrome / Normal
Rheumatoid arthritis / Normal
Schistosomiasis, Positive / Negative
Severely stunted / Moderately stunted
Stopping the probiotic intake 4 weeks / Probiotic administration 4 weeks
Stunted / Nonstunted
Summer / Winter
Tibetan / Bai
Tibetan / Han
Tibetan / Kazakh
Tibetan / Mongol
Tibetan / Uyghur
Tibetan / Zhuang
Tunapuco / Matses
Tunapuco / Norman
Type 1 diabetes / Normal
Type 2 diabetes / Normal
Ulcerative colitis / Normal
Urban / Rural
Urban Mongolian / Rural Mongolian
Urbanized town communities 40-69 year / Urbanized town communities Children
UTI patients, Adult household / Control
UTI patients, Ciprofloxacin / Control
UTI patients, Nitrofurantoin / Control
Uyghur / Bai
Uyghur / Han
Uyghur / Kazakh
Uyghur / Zhuang
Zhuang / Bai
Zhuang / Han
Taxon level
Genus
No rank
Species
Log2Ratio
>
=
<
Filter
Download
Detail
Taxon
Condition
Log2Ratio
P
value
k__Bacteria; p__Firmicutes; c__Negativicutes; o__Veillonellales; f__Veillonellaceae; g__Megasphaera
Asymptomatic C. difficile carriers / C. difficile infection
0.020
/
0
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Negativicutes; o__Veillonellales; f__Veillonellaceae; g__Megasphaera
Asymptomatic C. difficile carriers / Normal
-3.552
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Negativicutes; o__Veillonellales; f__Veillonellaceae; g__Megasphaera
C. difficile infection / Normal
0
/
0.234
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Negativicutes; o__Veillonellales; f__Veillonellaceae; g__Megasphaera
High gene count / Low gene count
0.526
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Negativicutes; o__Veillonellales; f__Veillonellaceae; g__Megasphaera
HIV, Negative / CD4 < 200
-3.531706649
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Negativicutes; o__Veillonellales; f__Veillonellaceae; g__Megasphaera
Multiple sclerosis treated / Normal
0.283
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Negativicutes; o__Veillonellales; f__Veillonellaceae; g__Megasphaera
Multiple sclerosis treated / Normal
0.747
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Negativicutes; o__Veillonellales; f__Veillonellaceae; g__Megasphaera
Multiple sclerosis untreated / Normal
3.99
<0.001
Loading...
k__Bacteria; p__Firmicutes; c__Negativicutes; o__Veillonellales; f__Veillonellaceae; g__Megasphaera
Children with PZQ, 1.1-2 years / 0-1 years
-0.325
0.001
Loading...
k__Bacteria; p__Firmicutes; c__Negativicutes; o__Veillonellales; f__Veillonellaceae; g__Megasphaera
Children with PZQ, 10.1-13 years / 0-1 years
0
/
0.118
0.001
Loading...
Showing 1 to 10 of 258 entries
,
10
20
50
100
entries per page
<
1
2
3
4
5
...
26
>
